DMK Annual CFI
$3.48 M
+$3.20 M+1132.37%
01 December 2022
Summary:
As of February 5, 2025, DMK annual cash flow from investing activities is $3.48 million, with the most recent change of +$3.20 million (+1132.37%) on December 1, 2022. During the last 3 years, it has risen by +$6.35 million (+221.54%).DMK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK Quarterly CFI
$1.77 M
+$1.63 M+1177.95%
01 September 2023
Summary:
As of February 5, 2025, DMK quarterly cash flow from investing activities is $1.77 million, with the most recent change of +$1.63 million (+1177.95%) on September 1, 2023. Over the past year, it has increased by +$988.20 thousand (+126.82%).DMK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK TTM CFI
$2.90 M
+$988.20 K+51.61%
01 September 2023
Summary:
As of February 5, 2025, DMK TTM cash flow from investing activities is $2.90 million, with the most recent change of +$988.20 thousand (+51.61%) on September 1, 2023. Over the past year, it has dropped by -$1.59 million (-35.40%).DMK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1132.4% | +126.8% | -35.4% |
| 3 y3 years | +221.5% | +3379.0% | +329.3% |
| 5 y5 years | +266.9% | +193.0% | +201.3% |
DMK Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -65.7% | -80.6% | -73.4% |
DMK Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $1.77 M(+1177.9%) | $2.90 M(+51.6%) |
| June 2023 | - | $138.30 K(-83.6%) | $1.91 M(-31.5%) |
| Mar 2023 | - | $841.80 K(+442.0%) | $2.79 M(-19.8%) |
| Dec 2022 | $3.48 M(+1132.4%) | $155.30 K(-80.1%) | $3.48 M(-22.5%) |
| Sept 2022 | - | $779.20 K(-23.4%) | $4.49 M(+22.1%) |
| June 2022 | - | $1.02 M(-33.7%) | $3.68 M(+65.6%) |
| Mar 2022 | - | $1.53 M(+31.5%) | $2.22 M(+685.6%) |
| Dec 2021 | $282.70 K(-129.9%) | $1.17 M(-3467.6%) | $282.80 K(-132.7%) |
| Sept 2021 | - | -$34.60 K(-92.2%) | -$863.90 K(-2.2%) |
| June 2021 | - | -$441.60 K(+8.7%) | -$883.20 K(-18.1%) |
| Mar 2021 | - | -$406.20 K(-2295.7%) | -$1.08 M(+13.9%) |
| Dec 2020 | -$946.20 K(-67.0%) | $18.50 K(-134.3%) | -$946.20 K(-25.3%) |
| Sept 2020 | - | -$53.90 K(-91.5%) | -$1.27 M(-19.5%) |
| June 2020 | - | -$636.50 K(+132.0%) | -$1.57 M(+6.7%) |
| Mar 2020 | - | -$274.30 K(-9.0%) | -$1.47 M(-48.5%) |
| Dec 2019 | -$2.87 M(-18.9%) | -$301.50 K(-16.5%) | -$2.87 M(-2.1%) |
| Sept 2019 | - | -$361.00 K(-32.9%) | -$2.93 M(-34.5%) |
| June 2019 | - | -$538.00 K(-67.7%) | -$4.47 M(-10.6%) |
| Mar 2019 | - | -$1.67 M(+357.3%) | -$5.00 M(+41.4%) |
| Dec 2018 | -$3.54 M(+69.3%) | -$364.30 K(-80.8%) | -$3.54 M(-6.4%) |
| Sept 2018 | - | -$1.90 M(+77.7%) | -$3.78 M(+38.5%) |
| June 2018 | - | -$1.07 M(+431.8%) | -$2.73 M(+22.6%) |
| Mar 2018 | - | -$201.10 K(-66.8%) | -$2.22 M(+6.6%) |
| Dec 2017 | -$2.09 M(-900.9%) | -$605.30 K(-28.9%) | -$2.09 M(+31.6%) |
| Sept 2017 | - | -$851.00 K(+50.0%) | -$1.59 M(+115.6%) |
| June 2017 | - | -$567.50 K(+784.0%) | -$736.00 K(-474.6%) |
| Mar 2017 | - | -$64.20 K(-38.4%) | $196.50 K(-24.6%) |
| Dec 2016 | $260.70 K(-102.6%) | -$104.30 K(<-9900.0%) | $260.70 K(-28.6%) |
| Sept 2016 | - | $0.00(-100.0%) | $365.00 K(0.0%) |
| June 2016 | - | $365.00 K(>+9900.0%) | $365.00 K(-105.2%) |
| Sept 2014 | - | $0.00(0.0%) | -$7.00 M(-30.0%) |
| Mar 2014 | -$10.00 M(<-9900.0%) | $0.00(-100.0%) | -$10.00 M(0.0%) |
| Dec 2013 | - | -$7.00 M(+133.3%) | -$10.00 M(+233.3%) |
| Sept 2013 | - | -$3.00 M(<-9900.0%) | -$3.00 M(<-9900.0%) |
| Mar 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2011 | - | -$500.00 K(-200.0%) | $0.00(-100.0%) |
| June 2011 | - | $500.00 K(>+9900.0%) | $275.00 K(+83.3%) |
| Mar 2011 | $150.00 K(+149.2%) | $0.00(0.0%) | $150.00 K(0.0%) |
| Dec 2010 | - | $0.00(-100.0%) | $150.00 K(-33.8%) |
| Sept 2010 | - | -$225.00 K(-160.0%) | $226.70 K(-38.7%) |
| June 2010 | - | $375.00 K(>+9900.0%) | $370.10 K(+514.8%) |
| Mar 2010 | $60.20 K(-112.0%) | $0.00(-100.0%) | $60.20 K(0.0%) |
| Dec 2009 | - | $76.70 K(-194.0%) | $60.20 K(-464.8%) |
| Sept 2009 | - | -$81.60 K(-225.3%) | -$16.50 K(-125.3%) |
| June 2009 | - | $65.10 K(>+9900.0%) | $65.10 K(-113.0%) |
| Mar 2009 | - | $0.00(0.0%) | -$500.00 K(0.0%) |
| Dec 2008 | -$500.00 K | $0.00(0.0%) | -$500.00 K(0.0%) |
| Sept 2008 | - | $0.00(-100.0%) | -$500.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | - | -$500.00 K(<-9900.0%) | -$500.00 K(<-9900.0%) |
| Mar 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2007 | - | $0.00(0.0%) | $9.13 M(-0.0%) |
| June 2007 | - | $0.00(0.0%) | $9.13 M(-10.0%) |
| Mar 2007 | - | $0.00(-100.0%) | $10.15 M(-0.1%) |
| Dec 2006 | $10.16 M(+4816.1%) | $9.13 M(>+9900.0%) | $10.16 M(+625.2%) |
| Sept 2006 | - | $1000.00(-99.9%) | $1.40 M(+30.6%) |
| June 2006 | - | $1.01 M(+9100.0%) | $1.07 M(+168.4%) |
| Mar 2006 | - | $11.00 K(-97.1%) | $399.60 K(+93.4%) |
| Dec 2005 | $206.60 K(-93.2%) | $376.60 K(-215.2%) | $206.60 K(-147.2%) |
| Sept 2005 | - | -$327.00 K(-196.5%) | -$437.30 K(-125.5%) |
| June 2005 | - | $339.00 K(-286.3%) | $1.71 M(-39.1%) |
| Mar 2005 | - | -$182.00 K(-31.9%) | $2.81 M(-7.5%) |
| Dec 2004 | $3.04 M(-252.3%) | -$267.30 K(-114.7%) | $3.04 M(-41.6%) |
| Sept 2004 | - | $1.82 M(+26.5%) | $5.21 M(-40.1%) |
| June 2004 | - | $1.44 M(+3030.4%) | $8.69 M(+65.1%) |
| Mar 2004 | - | $46.00 K(-97.6%) | $5.26 M(-363.4%) |
| Dec 2003 | -$2.00 M(-124.5%) | $1.90 M(-64.2%) | -$2.00 M(-53.0%) |
| Sept 2003 | - | $5.30 M(-367.0%) | -$4.25 M(-41.9%) |
| June 2003 | - | -$1.99 M(-72.5%) | -$7.31 M(+574.8%) |
| Mar 2003 | - | -$7.21 M(+1937.0%) | -$1.08 M(-113.3%) |
| Dec 2002 | $8.16 M(-277.3%) | -$354.00 K(-115.8%) | $8.16 M(-20.8%) |
| Sept 2002 | - | $2.24 M(-47.1%) | $10.30 M(+258.2%) |
| June 2002 | - | $4.24 M(+108.5%) | $2.88 M(-151.9%) |
| Mar 2002 | - | $2.03 M(+13.9%) | -$5.54 M(+20.3%) |
| Dec 2001 | -$4.60 M(-151.7%) | $1.79 M(-134.5%) | -$4.60 M(-37.7%) |
| Sept 2001 | - | -$5.18 M(+24.2%) | -$7.39 M(-314.5%) |
| June 2001 | - | -$4.17 M(-240.7%) | $3.44 M(-62.9%) |
| Mar 2001 | - | $2.97 M(-396.7%) | $9.27 M(+4.1%) |
| Dec 2000 | $8.90 M(-378.3%) | -$999.50 K(-117.7%) | $8.90 M(-18.3%) |
| Sept 2000 | - | $5.65 M(+241.1%) | $10.90 M(-429.7%) |
| June 2000 | - | $1.66 M(-36.3%) | -$3.31 M(+32.2%) |
| Mar 2000 | - | $2.60 M(+159.9%) | -$2.50 M(-21.8%) |
| Dec 1999 | -$3.20 M(-191.4%) | $1.00 M(-111.7%) | -$3.20 M(-33.3%) |
| Sept 1999 | - | -$8.56 M(-447.8%) | -$4.80 M(-205.2%) |
| June 1999 | - | $2.46 M(+29.6%) | $4.56 M(+11.3%) |
| Mar 1999 | - | $1.90 M(-416.7%) | $4.10 M(+17.1%) |
| Dec 1998 | $3.50 M(-127.6%) | -$600.00 K(-175.0%) | $3.50 M(-144.3%) |
| Sept 1998 | - | $800.00 K(-60.0%) | -$7.90 M(-42.3%) |
| June 1998 | - | $2.00 M(+53.8%) | -$13.70 M(+11.4%) |
| Mar 1998 | - | $1.30 M(-110.8%) | -$12.30 M(-3.1%) |
| Dec 1997 | -$12.70 M(+119.0%) | -$12.00 M(+140.0%) | -$12.70 M(+1054.5%) |
| Sept 1997 | - | -$5.00 M(-247.1%) | -$1.10 M(-126.8%) |
| June 1997 | - | $3.40 M(+277.8%) | $4.10 M(-183.7%) |
| Mar 1997 | - | $900.00 K(-325.0%) | -$4.90 M(-15.5%) |
| Dec 1996 | -$5.80 M(+286.7%) | -$400.00 K(-300.0%) | -$5.80 M(+7.4%) |
| Sept 1996 | - | $200.00 K(-103.6%) | -$5.40 M(-3.6%) |
| June 1996 | - | -$5.60 M(<-9900.0%) | -$5.60 M(<-9900.0%) |
| Mar 1996 | - | $0.00 | $0.00 |
| Dec 1995 | -$1.50 M | - | - |
FAQ
- What is DMK Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals annual CFI year-on-year change?
- What is DMK Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals quarterly CFI year-on-year change?
- What is DMK Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals TTM CFI year-on-year change?
What is DMK Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of DMK is $3.48 M
What is the all time high annual CFI for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high annual cash flow from investing activities is $10.16 M
What is DMK Pharmaceuticals annual CFI year-on-year change?
Over the past year, DMK annual cash flow from investing activities has changed by +$3.20 M (+1132.37%)
What is DMK Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of DMK is $1.77 M
What is the all time high quarterly CFI for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high quarterly cash flow from investing activities is $9.13 M
What is DMK Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, DMK quarterly cash flow from investing activities has changed by +$988.20 K (+126.82%)
What is DMK Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of DMK is $2.90 M
What is the all time high TTM CFI for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high TTM cash flow from investing activities is $10.90 M
What is DMK Pharmaceuticals TTM CFI year-on-year change?
Over the past year, DMK TTM cash flow from investing activities has changed by -$1.59 M (-35.40%)